JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
31/07/25 - 16:22
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)
06/05/25 - 17:41
Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)
14/03/25 - 16:29
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)
16/12/21 - 22:47
DiaSorin 2022-2025 Strategic Plan (552.15 KB)
11/11/21 - 16:56
DiaSorin business momentum and the Luminex acquisition drive Revenues and Profitability up in the first 9 months of 2021 (862.48 KB)
30/07/21 - 12:57
DiaSorin: Revenues and Profitability continue upward momentum in the First Half of 2021, with Guidance raised following the acquisition of Luminex (774.36 KB)
14/05/21 - 16:10
DiaSorin: significant growth in Revenues and Profitability in the first quarter 2021 (756.07 KB)
28/04/21 - 17:46
DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028 (529.64 KB)
28/04/21 - 7:54
DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028 (563.02 KB)
11/03/21 - 16:37
Dividend coupon date correction (414.99 KB)
11/03/21 - 15:31